<p>Vinorelbine is indicated:</p>

<ul>
	<li>In combination with&nbsp;cisplatin&nbsp;for first-line treatment of patients with locally advanced or metastatic&nbsp;non-small cell lung cancer&nbsp;(NSCLC)</li>
	<li>As a single agent, for the treatment of patients with metastatic NSCLC</li>
</ul>